Figures & data
Table 1. Summary of reports available on production of Apigenin particles.
Al Shaal L, Shegokar R, Müller RH. (2011). Production and characterization of antioxidant apigenin nanocrystals as a novel UV skin protective formulation. Int J Pharm 420:133–40. Al Shaal L, Müller RH, Shegokar R. (2010). SmartCrystal combination technology: scale up from lab to pilot scale and long term stability. Pharmazie 65:877–84. Zhang J, Huang Y, Liu D, et al. (2013). Preparation of apigenin nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement. Eur J Pharm Sci 48:740–7. Banerjee K, Banerjee S, Mandal M. (2017). Enhanced chemotherapeutic efficacy of apigenin liposomes in colorectal cancer based on flavone-membrane interactions. J Colloid Interface Sci 491:98–110. Banerjee K, Banerjee S, Das S, Mandal M. (2015). Probing the potential of apigenin liposomes in enhancing bacterial membrane perturbation and integrity loss. J Colloid Interface Sci 453:48–59. Jin X, Yang Q, Zhang Y. (2017). Synergistic apoptotic effects of apigenin TPGS liposomes and tyroservatide: implications for effective treatment of lung cancer. Ijn 12:5109–18. Shen LN, Zhang YT, Wang Q, et al. (2014). Enhanced in vitro and in vivo skin deposition of apigenin delivered using ethosomes. Int J Pharm 460:280–8. Zhai Y, Guo S, Liu C, et al. (2013). Preparation and in vitro evaluation of apigenin-loaded polymeric micelles. Colloids Surf A 429:24–30. Zhang Z, Cui C, Wei F, Lv H. (2017). Improved solubility and oral bioavailability of apigeninvia soluplus®/pluronic F127binary mixed micelles system. Drug Develop Ind Pharm 43:1. Kim BK, Cho AR, Park DJ. (2016). Enhancing oral bioavailability using preparations of apigenin-loaded W/O/W emulsions: in vitro and in vivo evaluations. Food Chem 206:85–91.